In vivo autofluorescence characteristics of pre- and post-treated oral submucous fibrosis: a pilot study.
OBJECTIVE
To compare the autofluorescence spectra of oral submucous fibrosis (OSF) with normal mucosa, the autofluorescence spectra of OSF before and after treatment with intralesional dexamethasone and hyaluronidase, the clinical improvement following treatment with the changes in autofluorescence spectra and to prove that autofluorescence spectroscopy is a good method for diagnosis and assessment of treatment effectiveness in OSF.


METHODS
The study was conducted at the Department of Oral Medicine and Radiology, Tamilnadu Government Dental College and Hospital, Chennai and Division of Medical Physics and Lasers, Department of Physics, Anna University, Chennai in 20 patients seeking medical management for symptomatic OSF and 20 patients who had dental caries only without any oral mucosal diseases and oral habits were used as normal controls. Their ages ranged from 20 to 40 years, including both male and female. In vivo fluorescence emission spectra were obtained using a handheld optical fiber probe attached to a Fluoromax-2 spectrofluorometer.


RESULTS
The fluorescence spectrum of OSF had an intense fluorescence emission at 385 nm with a secondary emission peak at 440 nm compared with that of the normal oral mucosa. The average fluorescence spectrum of the post treated OSF mucosa had a lesser intensity around 385 nm and a higher intensity around 440 nm than that of the pre treated OSF mucosa, thereby mimicking the normal oral mucosa. All the three clinical parameters (maximal mouth opening, tongue protrusion and the severity of burning sensation) showed a high statistical significance, with P < 0.001, as in the case of classification of pre treated OSF mucosa from the post treated OSF mucosa using the autofluorescence technique.


CONCLUSIONS
The change in the fluorescence emission spectrum for both normal and OSF mucosa before and after treatment can be explained by analyzing the changes in the fluorescence intensity of the endogenous fluorophores.
Vedeswari
C Ponranjini
CP
Department of Oral Medicine and Radiology, Government Dental College and Hospital, Chennai, Tamil Nadu, India.
Jayachandran
S
S
Ganesan
S
S
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D016022:Case-Control Studies; D003094:Collagen / Q000187:drug effects / Q000528:radiation effects*; D003907:Dexamethasone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005453:Fluorescence; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D015552:Injections, Intralesional; D008297:Male; D009061:Mouth Mucosa / Q000473:pathology* / Q000528:radiation effects; D009914:Oral Submucous Fibrosis / Q000188:drug therapy / Q000473:pathology*; D010865:Pilot Projects; D012016:Reference Values; D013050:Spectrometry, Fluorescence / Q000379:methods*; D016896:Treatment Outcome; D055815:Young Adult
D000893:Anti-Inflammatory Agents; D003907:Dexamethasone; D003094:Collagen; D006821:Hyaluronoglucosaminidase